Switchable targeting of solid tumors by BsCAR T cells

The development of chimeric antigen receptor (CAR) T cell therapy has become a critical milestone in modern oncotherapy. Despite the remarkable in vitro effectiveness, the problem of safety and efficacy of CAR T cell therapy against solid tumors is challenged by the lack of tumor-specific antigens r...

Descripción completa

Detalles Bibliográficos
Autores principales: Stepanov, Alexey V., Kalinin, Roman S., Shipunova, Victoria O., Zhang, Ding, Xie, Jia, Rubtsov, Yuri P., Ukrainskaya, Valeria M., Schulga, Alexey, Konovalova, Elena V., Volkov, Dmitry V., Yaroshevich, Igor A., Moysenovich, Anastasiia M., Belogurov, Alexey A., Zhang, Hongkai, Telegin, Georgij B., Chernov, Alexandr S., Maschan, Mikhail A., Terekhov, Stanislav S., Wu, Peng, Deyev, Sergey M., Lerner, Richard A., Gabibov, Alexander G., Altman, Sidney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674235/
https://www.ncbi.nlm.nih.gov/pubmed/36343224
http://dx.doi.org/10.1073/pnas.2210562119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674235/
https://www.ncbi.nlm.nih.gov/pubmed/36343224
http://dx.doi.org/10.1073/pnas.2210562119

Ejemplares similares